Fosun agrees to buy KKR-backed Indian drugmaker for $1.4 billion: source

HONG KONG (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd has agreed to buy Gland Pharma - backed by KKR & Co LP - for about $1.4 billion, a person with direct knowledge of the matter said, in India's largest inbound acquisition this year.

Fosun agrees to buy KKR-backed Indian drugmaker for $1.4 billion: source
Read More


Bagikan Berita Ini